Toronto Dominion Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.46M Sell
32,946
-16,753
-34% -$3.25M 0.01% 767
2025
Q4
$8.62M Buy
49,699
+8,578
+21% +$1.56M 0.01% 683
2025
Q3
$7.84M Sell
41,121
-4,160
-9% -$738K 0.01% 689
2025
Q2
$8.13M Buy
45,281
+6,265
+16% +$1.09M 0.01% 635
2025
Q1
$6.6M Sell
39,016
-20,670
-35% -$3.4M 0.01% 616
2024
Q4
$9M Buy
59,686
+3,840
+7% +$597K 0.01% 565
2024
Q3
$8.67M Buy
55,846
+851
+2% +$127K 0.02% 501
2024
Q2
$7.53M Sell
54,995
-8,490
-13% -$1.16M 0.01% 560
2024
Q1
$8.45M Buy
63,485
+672
+1% +$87.2K 0.01% 530
2023
Q4
$8.66M Buy
62,813
+5,240
+9% +$689K 0.01% 586
2023
Q3
$7.02M Sell
57,573
-1,987
-3% -$265K 0.01% 599
2023
Q2
$8.37M Buy
59,560
+1,811
+3% +$250K 0.01% 585
2023
Q1
$8.17M Sell
57,749
-1,397
-2% -$200K 0.01% 551
2022
Q4
$9.25M Buy
59,146
+8,215
+16% +$1.18M 0.01% 529
2022
Q3
$6.25M Sell
50,931
-9,864
-16% -$1.3M 0.01% 604
2022
Q2
$8.08M Sell
60,795
-10,628
-15% -$1.45M 0.02% 466
2022
Q1
$9.78M Sell
71,423
-99,596
-58% -$13.9M 0.01% 466
2021
Q4
$29.6M Buy
171,019
+103,334
+153% +$15.7M 0.04% 257
2021
Q3
$9.84M Buy
67,685
+10,039
+17% +$1.47M 0.02% 459
2021
Q2
$7.61M Sell
57,646
-7,924
-12% -$1.04M 0.01% 526
2021
Q1
$8.41M Sell
65,570
-13,606
-17% -$1.68M 0.01% 480
2020
Q4
$9.44M Buy
79,176
+3,243
+4% +$395K 0.02% 452
2020
Q3
$8.69M Sell
75,933
-12,137
-14% -$1.43M 0.02% 408
2020
Q2
$10M Sell
88,070
-14,133
-14% -$1.5M 0.03% 434
2020
Q1
$8.21M Sell
102,203
-23,780
-19% -$2.46M 0.03% 393
2019
Q4
$13.5M Buy
125,983
+26,448
+27% +$2.76M 0.02% 404
2019
Q3
$10.7M Sell
99,535
-97,889
-50% -$10M 0.02% 440
2019
Q2
$10.1M Buy
197,424
+103,433
+110% +$9.94M 0.02% 483
2019
Q1
$8.45M Buy
93,991
+12,094
+15% +$1.05M 0.01% 556
2018
Q4
$6.82M Sell
81,897
-7,404
-8% -$694K 0.01% 545
2018
Q3
$9.63M Buy
89,301
+1,446
+2% +$159K 0.02% 478
2018
Q2
$9.66M Buy
87,855
+14,378
+20% +$1.5M 0.02% 471
2018
Q1
$7.37M Buy
73,477
+14,479
+25% +$1.48M 0.02% 510
2017
Q4
$5.81M Buy
58,998
+6,958
+13% +$660K 0.02% 486
2017
Q3
$4.87M Buy
52,040
+5,401
+12% +$573K 0.02% 469
2017
Q2
$5.18M Buy
46,639
+9,242
+25% +$977K 0.02% 433
2017
Q1
$3.67M Buy
37,397
+13,207
+55% +$1.26M 0.01% 473
2016
Q4
$2.22M Buy
24,190
+19,829
+455% +$1.71M 0.01% 496
2016
Q3
$369K Buy
4,361
+3,316
+317% +$278K ﹤0.01% 667
2016
Q2
$85K Sell
1,045
-201
-16% -$15.3K ﹤0.01% 743
2016
Q1
$89K Sell
1,246
-3,428
-73% -$230K ﹤0.01% 752
2015
Q4
$333K Sell
4,674
-137
-3% -$9.21K ﹤0.01% 644
2015
Q3
$296K Buy
4,811
+508
+12% +$35.5K ﹤0.01% 659
2015
Q2
$312K Sell
4,303
-6
-0.1% -$443 ﹤0.01% 679
2015
Q1
$331K Sell
4,309
-1,915
-31% -$137K ﹤0.01% 644
2014
Q4
$417K Buy
6,224
+2,978
+92% +$188K ﹤0.01% 638
2014
Q3
$165K Hold
3,246
﹤0.01% 665
2014
Q2
$190K Buy
3,246
+522
+19% +$30.6K ﹤0.01% 739
2014
Q1
$158K Buy
2,724
+93
+4% +$4.98K ﹤0.01% 755
2013
Q4
$141K Buy
2,631
+2,321
+749% +$138K ﹤0.01% 750
2013
Q3
$19K Buy
310
+300
+3,000% +$18K ﹤0.01% 687
2013
Q2
$1K Buy
+10
New +$596 ﹤0.01% 780

Other funds holding DGX

Toronto Dominion Bank's DGX Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Quest Diagnostics (DGX) stake by 34% in Q1 2026, selling an estimated $3.25M and leaving 32,946 shares worth $6.46M. The position accounts for 0.01% of the portfolio, ranked #767.

Toronto Dominion Bank first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.6M in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Toronto Dominion Bank held 32,946 shares of Quest Diagnostics worth $6.46M as of Q1 2026.
  • Toronto Dominion Bank sold 16,753 Quest Diagnostics shares in Q1 2026, an estimated $3.25M.
  • Quest Diagnostics made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #767 holding.
  • Toronto Dominion Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Quest Diagnostics position peaked at $29.6M in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.